Showing results (1-10 of 170) with videos related to
Sort By:
Pageof 17
Cancers|October 26, 2024
De-Escalating Treatment Strategies for Patients with Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Early-Stage Breast CancerHikmat Abdel-RazeqBreast Cancer (Dove Medical Press)|June 29, 2026
Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for ImplementationHikmat Abdel-RazeqOncology Reviews|July 16, 2021
Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!Hikmat Abdel-RazeqHematology/Oncology and Stem Cell Therapy|May 25, 2018
Current frontline endocrine treatment options for women with hormone receptor-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-negative advanced-stage breast cancerHikmat Abdel-RazeqSaudi Medical Journal|April 26, 2017
The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelersHikmat Abdel-RazeqAnnals of Thoracic Medicine|October 29, 2010
Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improveHikmat Abdel-RazeqCancer Management and Research|June 14, 2019
Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancerHikmat Abdel-RazeqFrontiers in Oncology|October 2, 2023
Surgical options for patients with early-stage breast cancer and pathogenic germline variants: an oncologist perspectivesHikmat Abdel-RazeqDrug Design, Development and Therapy|July 14, 2026
Precision Endocrine-Based Combinations After CDK4/6 Inhibitor Progression in HR-Positive Metastatic Breast CancerHikmat Abdel-RazeqPageof 17